CLINICAL_TRIALS
trial_result
· 2019-03-27
Clinical Trial Update: Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus [Phase 4]
Summary
Phase 4 clinical trial evaluating empagliflozin added to insulin in Japanese patients with type 2 diabetes completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2019-03-27